AR088350A1 - Pasta, proceso de elaboracion y uso de la pasta - Google Patents
Pasta, proceso de elaboracion y uso de la pastaInfo
- Publication number
- AR088350A1 AR088350A1 ARP120103850A ARP120103850A AR088350A1 AR 088350 A1 AR088350 A1 AR 088350A1 AR P120103850 A ARP120103850 A AR P120103850A AR P120103850 A ARP120103850 A AR P120103850A AR 088350 A1 AR088350 A1 AR 088350A1
- Authority
- AR
- Argentina
- Prior art keywords
- paste according
- acids
- steroidal anti
- drug
- pasta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una pasta oral que comprende lo siguiente: (i) al menos una droga antiinflamatoria no esteroide, (ii) al menos un agente modificador de la viscosidad, (iii) un vehículo líquido. Reivindicación 2: Una pasta de acuerdo con la reivindicación 1, caracterizada porque la droga antiinflamatoria no esteroide se selecciona entre el grupo conformado por salicilatos, acetaminofeno, ácidos arilalcanoicos, ácidos 2-arilpropiónicos (profenos), ácidos N-arilantranílicos (ácidos fenámicos), oxicam, coxib, sulfonanilidas, drogas antiinflamatorias no esteroides que tienen propiedades inhibitorias tanto de la ciclooxigenasa (II) como de la lipooxigenasa -tales como tepoxalina- y mezclas de dos o más de ellos. Reivindicación 4: Una pasta de acuerdo con la reivindicación 3, caracterizada porque la droga antiinflamatoria no esteroide es meloxicam. Reivindicación 31: Una pasta de acuerdo con una cualquiera de las reivindicaciones anteriores, que comprende, además, al menos una droga adicional. Reivindicación 32: Una pasta de acuerdo con la reivindicación 31, caracterizada porque dicha droga adicional -al menos una- es un agente antimicrobiano, antibiótico, antiviral, anti-úlcera/anti-ácido o anti-cáncer, o una combinación de dos o más de ellos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1117858.9A GB201117858D0 (en) | 2011-10-17 | 2011-10-17 | Paste |
Publications (1)
Publication Number | Publication Date |
---|---|
AR088350A1 true AR088350A1 (es) | 2014-05-28 |
Family
ID=45219794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120103850A AR088350A1 (es) | 2011-10-17 | 2012-10-16 | Pasta, proceso de elaboracion y uso de la pasta |
Country Status (17)
Country | Link |
---|---|
US (1) | US20140287048A1 (es) |
EP (1) | EP2768478B1 (es) |
AR (1) | AR088350A1 (es) |
AU (1) | AU2012324605B2 (es) |
CA (1) | CA2852613A1 (es) |
CY (1) | CY1124227T1 (es) |
DK (1) | DK2768478T3 (es) |
ES (1) | ES2869880T3 (es) |
GB (1) | GB201117858D0 (es) |
HR (1) | HRP20210807T1 (es) |
HU (1) | HUE055148T2 (es) |
LT (1) | LT2768478T (es) |
PL (1) | PL2768478T3 (es) |
PT (1) | PT2768478T (es) |
RS (1) | RS62048B1 (es) |
SI (1) | SI2768478T1 (es) |
WO (1) | WO2013057461A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102014116221B4 (de) | 2014-11-06 | 2019-05-23 | Ferton Holding S.A. | Überwachungssystem und Verfahren zur Überwachung |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA987800B (en) * | 1997-08-27 | 1999-06-09 | Hexal Ag | Pharmaceutical composition of meloxicam |
KR100288190B1 (ko) * | 1998-02-09 | 2001-04-16 | 김용규 | 피록시캄 함유 알콜성 하이드로겔 조성물 |
EP0945131A1 (de) | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Perorale Wirkstoff-Suspension |
US6071523A (en) * | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
US6423697B1 (en) * | 1999-01-14 | 2002-07-23 | Mark Friedman | Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm |
US6924273B2 (en) * | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
JP2005533047A (ja) * | 2001-06-07 | 2005-11-04 | チョウ・コンサルティング・インコーポレイテッド | アフタ潰瘍および単純ヘルペス病変の予防および処置のための組成物および方法 |
US7816366B2 (en) * | 2002-02-12 | 2010-10-19 | Asymmetric Therapeutics, Llc | Compositions and methods for treating and preventing dermatoses |
CA2499093A1 (en) * | 2002-09-17 | 2004-04-01 | Nippon Boehringer Ingelheim Co., Ltd. | Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
US20050069590A1 (en) | 2003-09-30 | 2005-03-31 | Buehler Gail K. | Stable suspensions for medicinal dosages |
EP1582221A1 (en) * | 2004-03-31 | 2005-10-05 | Chiesi S.A. | Pharmaceutical oral compositions with a taste masking effect |
PL1824493T3 (pl) | 2004-12-06 | 2009-01-30 | Janssen Pharmaceutica Nv | Zawiesina zawierająca meloksykam do podawania doustnego |
US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
GB2438287A (en) * | 2006-05-19 | 2007-11-21 | Norbrook Lab Ltd | Stable aqueous suspension |
CA2763456C (en) * | 2009-05-27 | 2017-10-24 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
-
2011
- 2011-10-17 GB GBGB1117858.9A patent/GB201117858D0/en not_active Ceased
-
2012
- 2012-10-16 RS RS20210615A patent/RS62048B1/sr unknown
- 2012-10-16 CA CA2852613A patent/CA2852613A1/en not_active Abandoned
- 2012-10-16 HU HUE12779131A patent/HUE055148T2/hu unknown
- 2012-10-16 LT LTEP12779131.7T patent/LT2768478T/lt unknown
- 2012-10-16 PL PL12779131T patent/PL2768478T3/pl unknown
- 2012-10-16 US US14/352,464 patent/US20140287048A1/en not_active Abandoned
- 2012-10-16 ES ES12779131T patent/ES2869880T3/es active Active
- 2012-10-16 EP EP12779131.7A patent/EP2768478B1/en active Active
- 2012-10-16 PT PT127791317T patent/PT2768478T/pt unknown
- 2012-10-16 WO PCT/GB2012/000790 patent/WO2013057461A1/en active Application Filing
- 2012-10-16 SI SI201231923T patent/SI2768478T1/sl unknown
- 2012-10-16 AU AU2012324605A patent/AU2012324605B2/en not_active Ceased
- 2012-10-16 AR ARP120103850A patent/AR088350A1/es unknown
- 2012-10-16 DK DK12779131.7T patent/DK2768478T3/da active
-
2021
- 2021-05-13 CY CY20211100408T patent/CY1124227T1/el unknown
- 2021-05-19 HR HRP20210807TT patent/HRP20210807T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
PL2768478T3 (pl) | 2021-10-04 |
AU2012324605B2 (en) | 2017-02-23 |
SI2768478T1 (sl) | 2021-09-30 |
ES2869880T3 (es) | 2021-10-26 |
NZ624222A (en) | 2016-01-29 |
GB201117858D0 (en) | 2011-11-30 |
HUE055148T2 (hu) | 2021-11-29 |
DK2768478T3 (da) | 2021-05-25 |
EP2768478B1 (en) | 2021-03-17 |
WO2013057461A1 (en) | 2013-04-25 |
PT2768478T (pt) | 2021-05-27 |
AU2012324605A1 (en) | 2014-05-29 |
US20140287048A1 (en) | 2014-09-25 |
EP2768478A1 (en) | 2014-08-27 |
LT2768478T (lt) | 2021-07-12 |
HRP20210807T1 (hr) | 2021-06-25 |
CA2852613A1 (en) | 2013-04-25 |
CY1124227T1 (el) | 2022-05-27 |
RS62048B1 (sr) | 2021-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019000510A1 (es) | Adenovirus armado con un activador de células t biespecífico (bite). | |
CO2017001035A2 (es) | “2-(morfolin-4-il)-1,7-naftiridinas sustituidas, composiciones y combinaciones farmacéuticas que las comprenden, y compuestos intermediarios | |
CL2015001864A1 (es) | Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih. | |
CL2016002414A1 (es) | Compuestos derivados de nucleosidos, inhibidores de la transcriptasa inversas composición farmacéutica que los comprende y su uso en el tratamiento de una infección por vih. pct | |
CL2015003117A1 (es) | Modificaciones en la estructura cristalina | |
CL2013001339A1 (es) | Compuestos derivados heterociclicos condensados, con actividad antiviral; composicion farmaceutica que los comprende; y su uso para la prevencion o tratamiento de la infeccion de vih. | |
CL2008003406A1 (es) | Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih. | |
CL2011002878A1 (es) | Compuestos derivados de tieno[2,3-b]piridinas, inhibidores de la replicacion del virus vih; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para prevenir o tratar una infeccion por vih. | |
CL2013003019A1 (es) | Compuestos derivados de benzotiazol; composicion farmaceutica que los comprende; y su uso en el tratamiento del vih. | |
CU20140068A7 (es) | Triazolopiridinas sustituidas | |
CL2012003421A1 (es) | Compuestos derivados de 3-amino-n-(4-carbamoilpiridin-3-il)(aril/heteroaril)-2-carboxamida; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad del snc, oncologica, entre otras. pct fase nacional | |
UY33183A (es) | Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento | |
ECSP13012569A (es) | Formulación de premezcla de dexmedetomidina | |
ECSP099581A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
DOP2016000253A (es) | Nuevos compuestos | |
CL2016000008A1 (es) | Tratamiento de lesiones inflamatorias de rosacea con ivermectina. | |
CU20120171A7 (es) | Triazolopiridinas sustituidas | |
UY35293A (es) | Isotiazoles sustituidos con amino | |
CL2012003038A1 (es) | Polietilenglicol conjugado a factor viia; composicion farmacéutica que comprende dicho polietilenglicol conjugado a factor viia; uso de una composicion farmaceutica para tratar enfermedad o trauma de la coagulacion de la sangre en un paciente que la necesita; proceso para preparar el siguiente polietilenglicol conjugado a factor viia. | |
UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
UY34008A (es) | ?formas en estado sólido de inhibidor de hiv, composición farmacéutica, uso de la misma, y procesos para preparar dichas formas?. | |
UY35344A (es) | Oestra-1,3,5(10),16-tetraeno-3-carboxamidas | |
UY35848A (es) | Tienopirimidinas | |
BR112016022722B8 (pt) | Composto, composição farmacêutica que o comprende e uso do mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |